Recall archive / FDA drug enforcement
Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180... — FDA record D-0098-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Dec 20, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.
- Reason
- Failed Impurities/Degradation specifications
- Classification
- Class II
- Recalling firm
- RemedyRepack Inc.
- Quantity
- 132 Cards of 30 = 3960 Tablets
- Agency-reported status
- Terminated
- Source record identifier
- D-0098-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: J0599794-022322, exp. date 02/28/2023; J0621369-052622, exp. date 06/30/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Product was distributed to one account in PA.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Jan 18, 2023
- Recall initiation date
- Dec 20, 2022
- Center classification date
- Jan 6, 2023
- Termination date
- Mar 3, 2023
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.